Dark

Check out our Level2View

SRDX
Surmodics, Inc. Common Stock
stock NASDAQ

Inactive

Nov 18, 2025

42.98USD+0.350%(+0.15)5,342,690

Pre-market

0.00USD-100.000%(-42.83)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 11, 2022

08:35AM EST Surmodics to Present at Sidoti & Company Virtual Investor Conference Business Wire

Jan 5, 2022

07:00AM EST Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appointment of two new board members: Lisa Wipperman Heine and William P. Burke. GlobeNewswire Inc

Nov 10, 2021

12:24PM EST Needham Maintains Buy on Surmodics, Lowers Price Target to $70 Benzinga

07:39AM EST Surmodics Sees FY22 Adj. EPS $(1.75)-$(1.25) vs $0.92 Estimate, Sales $97M-$101M vs $118.12M Est. Benzinga

07:38AM EST Surmodics Q4 Adj. EPS $(0.10) Beats $(0.25) Estimate, Sales $24.00M Beat $23.06M Estimate Benzinga

07:38AM EST Surmodics Q4 Revenue Of $24.0 Mln, Increase Of 6% Year-over-year RTTNews

07:30AM EST Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance Business Wire

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 2, 2021

08:30AM EDT Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10 Business Wire

Sep 29, 2021

08:20AM EDT Surmodics Reports Successful First Patient Uses Of Sublime Radial Access .018 RX PTA Dilatation Catheter RTTNews

08:20AM EDT Surmodics Highlights First Patient Uses Of Sublime Radial Access .018 RX PTA Dilatation Catheter Benzinga

08:15AM EDT Surmodics Announces Successful First Patient Uses of Sublime(tm) Radial Access .018 RX PTA Dilatation Catheter Business Wire

Sep 8, 2021

06:10AM EDT Needham Maintains Buy on Surmodics, Raises Price Target to $76 Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 4, 2021

08:29AM EDT Surmodics Raises FY21 Adj. EPS Guidance From $0.10-$0.35 To $0.16-$0.31 vs $0.25 Est. Benzinga

08:26AM EDT Surmodics Q3 Adj. EPS $(0.17), Inline, Sales $23.87M Beat $23.31M Estimate Benzinga

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

07:50AM EDT Surmodics Narrows FY21 EPS Guidance From $0.10-$0.35 To $0.16-$0.31 Vs. $0.25 Est., Raises FY21 Sales Guidance From $101M-$105M To $103.5M-$105.5M Vs. $103.5M est. Benzinga

07:48AM EDT Recap: Surmodics Q3 Earnings Benzinga

07:48AM EDT Surmodics Q3 EPS $(0.17), Inline, Sales $23.87M Beat $23.31M Estimate Benzinga

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 29, 2021

08:31AM EDT Surmodics Announces Successful First Patient Use of Pounce Thrombectomy System Benzinga

Jul 6, 2021

01:04PM EDT UPDATE: Needham Earlier On Surmodics: Firm Highlights Acquisition Of Vetex Medical For Up To $47M Which Complements Co.'s Pounce Arterial Clot Removal Device Supporting Bullish Thesis Of Continued Focus On Whole Product Solutions Benzinga

01:04PM EDT Needham Earlier Reiterated Buy Rating On Surmodics With $68 Price Target Benzinga

08:11AM EDT Surmodics Acquires Vetex Medical Limited For Upfront Payment OF $39.9M And Additional Payments Of Up To $7M Benzinga

Apr 28, 2021

07:42AM EDT Recap: Surmodics Q2 Earnings Benzinga

07:35AM EDT Surmodics Q2 EPS $0.62 Misses $0.63 Estimate, Sales $35.00M Beat $32.95M Estimate Benzinga

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 16, 2021

08:01AM EDT The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs Benzinga

Apr 7, 2021

07:58AM EDT The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award Benzinga

Apr 6, 2021

08:05AM EDT The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga

Apr 1, 2021

08:43AM EDT Surmodics Announces Successful First Patient Uses of Two Sublime Radial Access Platform Devices Benzinga

07:46AM EDT The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract Benzinga

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

Mar 11, 2021

08:19AM EST The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga

Mar 10, 2021

07:26AM EST The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link Benzinga

Mar 9, 2021

09:17AM EST The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data Benzinga

Feb 10, 2021

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

07:44AM EST Recap: Surmodics Q1 Earnings Benzinga

07:34AM EST Surmodics Q1 Adj. EPS $0.02 Beats $(0.09) Estimate, Sales $22.30M Miss $22.37M Estimate Benzinga

04:05AM EST Earnings Scheduled For February 9, 2021 Benzinga

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Jan 25, 2021

08:27AM EST Surmodic Announces 12-Month Data From Co's TRANSCEND Trial Present At LINC 2021 Event; Says SurVeil Drug Coated Balloon Demonstrate 'Non-Inferior Safety And Efficacy' Benzinga

Jan 22, 2021

10:00AM EST Needham Reiterates Buy, $61 Price on Surmodics; Expects TRANSCEND Trial to Meet Primary Endpoints, Show 'Non-Inferiority to Medtronic's' Which In Turn Should Trigger Additional Milestone Payments From Partner, Abbott Labs Benzinga

Jan 12, 2021

08:08AM EST Surmodics Reports TRANSCEND Trial 12-Month Data To Be Presented At Leipzig Interventional Course Event Jan. 25 Benzinga

Nov 4, 2020

04:35PM EST Surmodics Q4 EPS $(0.18) Misses $(0.08) Estimate, Sales $22.54M Beat $20.77M Estimate Benzinga

04:33PM EST Recap: Surmodics Q4 Earnings Benzinga

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

04:41AM EST Earnings Scheduled For November 4, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Sep 23, 2020

08:37AM EDT Surmodics Receives FDA 510(k) Clearance For Pounce Thrombus Retrieval System Benzinga

Aug 5, 2020

04:26PM EDT Surmodics Q3 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $26.90M Beat $23.75M Estimate Benzinga

04:20PM EDT Surmodics Reports Receives FDA 510(k) Clearance For Sublime Radial Access 0.014 RX PTA Dilatation Catheter Benzinga

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Jul 23, 2020

05:24AM EDT Needham Upgrades Surmodics to Buy, Announces $61 Price Target Benzinga

Share